News for Petros Pharmaceuticals, Inc. (PTPI)

The Company Intends to Appeal the Delisting Determination NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" o

The Company Intends to Appeal the Delisting Determination NEW YORK, NY / ACCESS Newswire / May 21, 2025 / Petros Pharmaceuticals, Inc. (Nasdaq:PTPI) ("Petros" o

Petros Pharmaceuticals (PTPI) has been notified by the Nasdaq Stock Market about a decision to halt trading and remove the company's common stock from their lis

Petros Pharmaceuticals (PTPI) will transition from Nasdaq to OTC Markets on May 22, 2025. The company plans to appeal the Nasdaq delisting decision and

Shares of Toll Brothers, Inc. TOL rose sharply in today's pre-market after the company posted stronger-than-expected earnings and sales results for the second q...

Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order NEW YORK, N

Petros Pharmaceuticals (PTPI) enhances AI platform to aid Rx-to-OTC drug switches. New features include Deep Fake detection and improved facial recognit

Licensable platform intended to facilitate industry compliance with President Trump's recent Executive Order to expand access to medicines through OTC approvals

Petros Pharmaceuticals (PTPI) is advancing its strategic transition towards becoming a smart healthcare technology entity by developing a Software as a Service

Petros Pharmaceuticals (PTPI) is developing an innovative SaaS platform to facilitate prescription-to-OTC drug transitions. The platform, designed with

Company's AI and Big Data technology positioned to drive strong industry collaborationCompany also announces certain corporate actions NEW YORK, NY / ACCESS New

PTPI has announced a reverse stock split of its common stock, where shareholders will receive one post-split share for every 25 pre-split shares they hold. This

Petros Pharmaceuticals aligns with April 15, 2025, Executive Order to facilitate Rx-to-OTC transitions using AI and Big Data. 1-for-25 reverse stock spl

Petros Pharmaceuticals (PTPI) is strategically positioning itself to align with the current regulatory environment following President Trump's April 15, 2025 Ex

U.S. stocks traded mixed this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded u...

U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 1% on Wednesday. Following the market opening Wednesday, the Dow traded up 0.35...

Shares of GameStop Corp. GME rose sharply in today's pre-market trading after reporting better-than-expected fourth-quarter earnings. GameStop reported fourth-...

Proprietary technology utilizing AI and big data integrations to enable Rx to OTC switch candidates across multiple indications NEW YORK, NY / ACCESS Newswire /

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 100 points on Tuesday. The Dow traded down 0.38% to 44,378.28 whil...